Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies.
Of the 16 non-structural proteins (Nsps) encoded by SARS CoV-2, Nsp3 is the largest and plays important roles in the viral life cycle. Being a large, multidomain, transmembrane protein, Nsp3 has been the most challenging Nsp to characterize. Encoded within Nsp3 is the papain-like protease domain (PL...
| Published in: | PLoS ONE |
|---|---|
| Main Authors: | Lee A Armstrong, Sven M Lange, Virginia Dee Cesare, Stephen P Matthews, Raja Sekhar Nirujogi, Isobel Cole, Anthony Hope, Fraser Cunningham, Rachel Toth, Rukmini Mukherjee, Denisa Bojkova, Franz Gruber, David Gray, Paul G Wyatt, Jindrich Cinatl, Ivan Dikic, Paul Davies, Yogesh Kulathu |
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Online Access: | https://doi.org/10.1371/journal.pone.0253364 |
Similar Items
Assessing nanobody interaction with SARS-CoV-2 Nsp9.
by: Gennaro Esposito, et al.
Published: (2024-01-01)
by: Gennaro Esposito, et al.
Published: (2024-01-01)
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
by: Denisa Bojkova, et al.
Published: (2022-05-01)
by: Denisa Bojkova, et al.
Published: (2022-05-01)
Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2
by: Martin Michaelis, et al.
Published: (2019-12-01)
by: Martin Michaelis, et al.
Published: (2019-12-01)
Correction: Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies
Published: (2024-01-01)
Published: (2024-01-01)
COVID-19-Related Coagulopathy—Is Transferrin a Missing Link?
by: Katie-May McLaughlin, et al.
Published: (2020-07-01)
by: Katie-May McLaughlin, et al.
Published: (2020-07-01)
Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy
by: Denisa Bojkova, et al.
Published: (2021-10-01)
by: Denisa Bojkova, et al.
Published: (2021-10-01)
Redefining NSP12 activity in SARS-CoV-2 and its regulation by NSP8 and NSP7
by: Deepa Singh, et al.
Published: (2025-03-01)
by: Deepa Singh, et al.
Published: (2025-03-01)
A conserved motif within the NSP2 of SARS-CoV-2 is required for processing of the distal NSP1/NSP2 junction by NSP3
by: Thea Kristensen, et al.
Published: (2025-07-01)
by: Thea Kristensen, et al.
Published: (2025-07-01)
Surfactant Enhanced Chromium Removal Using a Silica Gel Column
by: N. Rajesh, et al.
Published: (2001-06-01)
by: N. Rajesh, et al.
Published: (2001-06-01)
Discovery of anti-SARS-CoV-2 secondary metabolites from the heartwood of Pterocarpus santalinus using multi-informative molecular networking
by: Andreas Wasilewicz, et al.
Published: (2023-06-01)
by: Andreas Wasilewicz, et al.
Published: (2023-06-01)
Investigation of COVID-19 virus mutagenicity and the effect of the NSP13, NSP14, and NSP16 on the -1 ribosomal frameshifting
by: Ali Khanifar, et al.
Published: (2024-07-01)
by: Ali Khanifar, et al.
Published: (2024-07-01)
Association of rotavirus viroplasms with microtubules through NSP2 and NSP5
by: Claudio Cabral-Romero, et al.
Published: (2006-09-01)
by: Claudio Cabral-Romero, et al.
Published: (2006-09-01)
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
by: Chun-Kit Yuen, et al.
Published: (2020-01-01)
by: Chun-Kit Yuen, et al.
Published: (2020-01-01)
Nutrient regulation of lipochitooligosaccharide recognition in plants via NSP1 and NSP2
by: Xin-Ran Li, et al.
Published: (2022-10-01)
by: Xin-Ran Li, et al.
Published: (2022-10-01)
Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2
by: Qi Peng, et al.
Published: (2020-06-01)
by: Qi Peng, et al.
Published: (2020-06-01)
Characterization of ACE Inhibitors and AT<sub>1</sub>R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell Model
by: Philipp Reus, et al.
Published: (2021-08-01)
by: Philipp Reus, et al.
Published: (2021-08-01)
Investigation of protein-protein interactions and hotspot region on the NSP7-NSP8 binding site in NSP12 of SARS-CoV-2
by: José Xavier Lima Neto, et al.
Published: (2024-01-01)
by: José Xavier Lima Neto, et al.
Published: (2024-01-01)
Superimmunity by pan-sarbecovirus nanobodies
by: Yufei Xiang, et al.
Published: (2025-07-01)
by: Yufei Xiang, et al.
Published: (2025-07-01)
Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase
by: Roberto Benoni, et al.
Published: (2021-08-01)
by: Roberto Benoni, et al.
Published: (2021-08-01)
NTPase and 5'-RNA triphosphatase activities of Chikungunya virus nsP2 protein.
by: Yogesh A Karpe, et al.
Published: (2011-01-01)
by: Yogesh A Karpe, et al.
Published: (2011-01-01)
Correction to “Scalable Inhibitors of the Nsp3–Nsp4 Coupling in SARS-CoV-2”
by: Abdul-Rahman Azizogli, et al.
Published: (2024-08-01)
by: Abdul-Rahman Azizogli, et al.
Published: (2024-08-01)
Antiviral Potential of <i>Antillogorgia americana</i> and <i>elisabethae</i> Natural Products against nsp16–nsp10 Complex, nsp13, and nsp14 Proteins of SARS-CoV-2: An In Silico Investigation
by: Omkar Pokharkar, et al.
Published: (2023-07-01)
by: Omkar Pokharkar, et al.
Published: (2023-07-01)
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
by: Peter Bannas, et al.
Published: (2017-11-01)
by: Peter Bannas, et al.
Published: (2017-11-01)
Enisamium Inhibits SARS-CoV-2 RNA Synthesis
by: Stefano Elli, et al.
Published: (2021-09-01)
by: Stefano Elli, et al.
Published: (2021-09-01)
The kinetics of nsp7-11 polyprotein processing and impact on complexation with nsp16 among human coronaviruses
by: Kira Schamoni-Kast, et al.
Published: (2025-09-01)
by: Kira Schamoni-Kast, et al.
Published: (2025-09-01)
Special Issue: Nanobody
by: Patrick Chames, et al.
Published: (2020-03-01)
by: Patrick Chames, et al.
Published: (2020-03-01)
Nanobodies that Neutralize HIV
by: Robin A. Weiss, et al.
Published: (2019-07-01)
by: Robin A. Weiss, et al.
Published: (2019-07-01)
Development of an Anti-Zearalenone Nanobody Phage Display Library and Preparation of Specific Nanobodies
by: Ying Zeng, et al.
Published: (2025-02-01)
by: Ying Zeng, et al.
Published: (2025-02-01)
Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology
by: Keming Lin, et al.
Published: (2024-04-01)
by: Keming Lin, et al.
Published: (2024-04-01)
Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16
by: Huan Wang, et al.
Published: (2023-12-01)
by: Huan Wang, et al.
Published: (2023-12-01)
Cleavage sequence specificity of Nsp15
by: John V. McGuire, et al.
Published: (2025-12-01)
by: John V. McGuire, et al.
Published: (2025-12-01)
Coronavirus Inhibitors Targeting nsp16
by: Ejlal A. Omer, et al.
Published: (2023-01-01)
by: Ejlal A. Omer, et al.
Published: (2023-01-01)
The coronavirus nsp14 exoribonuclease interface with the cofactor nsp10 is essential for efficient virus replication and enzymatic activity
by: Samantha L. Grimes, et al.
Published: (2025-02-01)
by: Samantha L. Grimes, et al.
Published: (2025-02-01)
Structure-Based Virtual Screening for Methyltransferase Inhibitors of SARS-CoV-2 nsp14 and nsp16
by: Kejue Wu, et al.
Published: (2024-05-01)
by: Kejue Wu, et al.
Published: (2024-05-01)
Roncus meledae n.sp. and Neobisium oculatum n.sp., from the island of Mljet, Dalmatia (Neobisiidae, Pseudoscorpiones)
by: Ćurčić B.P.M., et al.
Published: (2012-01-01)
by: Ćurčić B.P.M., et al.
Published: (2012-01-01)
Nanobodies for Medical Imaging: About Ready for Prime Time?
by: Léa Berland, et al.
Published: (2021-04-01)
by: Léa Berland, et al.
Published: (2021-04-01)
Selecting Nanobodies Specific for the Epidermal Growth Factor from a Synthetic Nanobody Library
by: Yunier Serrano-Rivero, et al.
Published: (2023-05-01)
by: Yunier Serrano-Rivero, et al.
Published: (2023-05-01)
New or rare frogs from the Coastal Ranges of Brazil: eleutherodactylus venancioi n.sp., E. hoehnei n.sp. Holoaden bradei n.sp. e H. lüderwaldti Mir. Rib., 1920 Anfíbios novos e raros das Serras Costeiras do Brasil: eleutherodactylus venancioi n.sp., E. hoehnei n.sp. Holoaden bradei n.sp. e H. lüderwaldti Mir. Rib., 1920
by: Bertha Lutz
Published: (1958-12-01)
by: Bertha Lutz
Published: (1958-12-01)
Drug-resistant cell lines in cancer
by: Jindrich Cinatl, et al.
Published: (2024-09-01)
by: Jindrich Cinatl, et al.
Published: (2024-09-01)
Publisher Correction: The kinetics of nsp7-11 polyprotein processing and impact on complexation with nsp16 among human coronaviruses
by: Kira Schamoni-Kast, et al.
Published: (2025-10-01)
by: Kira Schamoni-Kast, et al.
Published: (2025-10-01)
Similar Items
-
Assessing nanobody interaction with SARS-CoV-2 Nsp9.
by: Gennaro Esposito, et al.
Published: (2024-01-01) -
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
by: Denisa Bojkova, et al.
Published: (2022-05-01) -
Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2
by: Martin Michaelis, et al.
Published: (2019-12-01) -
Correction: Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies
Published: (2024-01-01) -
COVID-19-Related Coagulopathy—Is Transferrin a Missing Link?
by: Katie-May McLaughlin, et al.
Published: (2020-07-01)
